Mark DeLong - Oct 23, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Business & Strat Officer
Signature
/s/ David Watson, attorney-in-fact for Mark DeLong
Stock symbol
APLS
Transactions as of
Oct 23, 2023
Transactions value $
-$6,031
Form type
4
Date filed
10/24/2023, 04:18 PM
Previous filing
Feb 22, 2023
Next filing
Jan 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$6.03K -131 -0.25% $46.04 51.6K Oct 23, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on a Restricted Stock Unit release.
F2 This includes 412 shares from 04/30/2023 ESPP purchase.